Gingerbread Capital

Gingerbread Capital invests exclusively in women-founded companies, with a deliberate focus on consumer and healthcare markets where the intersection of female leadership and female end-users is structurally under-funded. From its Menlo Park base, the firm operates across a wide stage range, backing companies from seed through Series C, and its healthcare portfolio reflects a working belief that women’s health and consumer health together represent a serious, durable investment category rather than a niche. Portfolio companies include Maven Clinic and Midi Health, both of which build for life-stage healthcare needs that mainstream venture has historically priced poorly.

The thesis is women’s and reproductive health and consumer wellness, with an explicit preference for companies led by women founders. AI focus is real where the technology improves clinical reasoning or consumer experience, and the firm is comfortable engaging with products that combine clinical credibility with consumer scale. Founders building outside the women-founded criterion are not part of the universe; founders inside it should expect a serious thesis-aligned partner.

Checks fall in the two hundred and fifty thousand to one million dollar range and are deployed across a wide stage range from seed through Series C. That range allows the firm to engage early and follow on through later rounds, and on the cap table the leverage is the access to a partner whose entire portfolio is consistent with the founder’s category. Geography is centered on the United States, with Menlo Park as the operating base.

The firm is structured as a focused, partner-led operation rather than a large multi-strategy platform. That structure shapes the engagement, with founders interacting directly with the principals rather than through an associate layer.

The approach is thesis-driven and operationally specific. The firm is most useful on questions of consumer trust, clinical credibility for products operating outside traditional channels, fundraising strategy for companies that have historically been under-priced by mainstream investors, and the often-overlooked work of building a consumer-health brand that earns repeat use. The partner network is one of the most concentrated in the women-founded segment, which makes it materially easier for founders to find later-stage co-investors and operational partners aligned with the category. Process is direct, with diligence focused on the specifics of the customer and the founder. Follow-on participation across rounds is common and consistent with the firm’s stage flexibility. For women founders building in healthcare and consumer health, looking for a thesis-aligned partner with a long view, the fit is direct.